Medtronic seeks pharma partners for Alzheimer’s treatments

According to a receint article in FierceMedicalDevices, Medtronic ($MDT) believes its  pump technology could pair well with the next generation of Alzheimer’s  treatments, and the company is on the hunt for pharmaceutical partners.

Lisa Shafer, Medtronic’s director of CNS drug delivery, told Bloomberg that less than 1% of intravenous treatments can get past the  blood-brain barrier on their own, but, if paired with the company’s  already-on-the-market pumps, Alzheimer’s drugs could be delivered straight to  the brain.

Medtronic has proof of concept for the potential pairing, and now it needs  only to recruit partners, Shafer said.

Read more of this September 18, 2012 article by  Damian Garde at FierceMedicalDevices : Medtronic seeks pharma partners for Alzheimer’s treatments – FierceMedicalDevices

Posted in AZBio News, BioScience and tagged , , .